CINECA IRIS Institutional Research Information System

FALLAHI, POUPAK
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.153
EU - Europa 5.718
AS - Asia 2.027
AF - Africa 151
SA - Sud America 29
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.822
IT - Italia 2.562
SE - Svezia 1.187
CN - Cina 1.086
BG - Bulgaria 707
VN - Vietnam 404
CA - Canada 327
DE - Germania 326
GB - Regno Unito 203
FI - Finlandia 196
TR - Turchia 196
UA - Ucraina 153
RU - Federazione Russa 145
SG - Singapore 141
CI - Costa d'Avorio 81
HK - Hong Kong 77
IN - India 59
CH - Svizzera 44
FR - Francia 40
BE - Belgio 37
SN - Senegal 34
NG - Nigeria 26
IQ - Iraq 23
NL - Olanda 23
PL - Polonia 23
BR - Brasile 14
ES - Italia 12
RO - Romania 11
AT - Austria 10
CZ - Repubblica Ceca 9
IR - Iran 9
IE - Irlanda 7
EU - Europa 6
GR - Grecia 6
JP - Giappone 6
PT - Portogallo 6
AU - Australia 5
EG - Egitto 5
CO - Colombia 4
HU - Ungheria 4
IL - Israele 4
KR - Corea 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
CL - Cile 3
RS - Serbia 3
TW - Taiwan 3
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MU - Mauritius 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 24.091
Salva come PNG Salva come JPEG
Città #
Fairfield 2.488
Woodbridge 2.049
Houston 1.379
Chandler 1.180
Ann Arbor 1.165
Ashburn 1.115
Seattle 1.067
Serra 985
Wilmington 863
Cambridge 861
Sofia 707
Milan 590
Beijing 440
New York 431
Princeton 343
Ottawa 307
Lawrence 286
Medford 264
Nanjing 193
Jacksonville 184
Izmir 180
Des Moines 179
Dong Ket 174
San Diego 124
Florence 106
Dearborn 87
Abidjan 81
Hong Kong 73
Rome 70
Boulder 65
Nanchang 62
Pisa 56
Frankfurt am Main 52
Kunming 50
London 49
Redwood City 47
Bremen 45
Falls Church 42
Hebei 41
Norwalk 40
Changsha 39
Shenyang 39
Brussels 36
Bern 34
Dakar 34
Jüchen 31
Los Angeles 31
Ogden 27
Washington 27
Jiaxing 25
Lagos 25
Rho 25
Hefei 24
Pune 24
Boardman 23
Tianjin 23
Chicago 22
Phoenix 20
Sulaymaniyah 20
Indiana 19
Warsaw 17
Zhengzhou 17
Guangzhou 16
Massa 16
San Francisco 16
Carrara 14
Lancaster 13
Parma 13
Detroit 12
Kent 11
Chengdu 10
Jinan 10
Amsterdam 9
Auburn Hills 9
Changchun 9
Lanzhou 9
Shanghai 9
Sundbyberg 9
Vienna 9
Kilburn 8
Dublin 7
Edinburgh 7
Hangzhou 7
Ningbo 7
Renton 7
São Paulo 7
Bergamo 6
Fremont 6
Grafing 6
Livorno 6
Nürnberg 6
Toronto 6
Wuhan 6
Camaiore 5
Cascina 5
Grosseto 5
Lucca 5
Redmond 5
Boston 4
Budapest 4
Totale 19.421
Salva come PNG Salva come JPEG
Nome #
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 185
A new class of tyrosine kinase inhibitors, “pyrazolo[3,4-d]pyrimidinic”compounds, has antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer 183
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 160
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 156
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 155
B-cells and mixed cryoglobulinemia. 153
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 152
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 146
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 146
HCV-related autoimmune and neoplastic disorders: the HCV syndrome 140
3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats 139
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. 139
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 138
Increased CXCL9 Serum Levels in Hepatitis C-Related Mixed Cryoglobulinemia, with Autoimmune Thyroiditis, Associated with High Levels of CXCL10 138
Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts. 136
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 135
Sorafenib and Thyroid Cancer 130
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 129
Cytokines and HCV-Related Disorders. 127
Sunitinib in the treatment of thyroid cancer 127
Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. 124
Cytokines and HCV-related autoimmune disorders 122
CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes 122
Cabozantinib in Thyroid Cancer 121
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. 120
The Endocrinology of Liver Disease. 120
RET TKI: Potential Role in Thyroid Cancers 120
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 120
Thyroid involvement in hepatitis C - Associated mixed cryoglobulinemia 120
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 118
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 118
An iron regulatory gene signature in breast cancer: More than a prognostic genetic profile? 117
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 117
Sorafenib in the treatment of thyroid cancer 117
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 117
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 116
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 116
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 116
Aggressive thyroid cancer: targeted therapy with sorafenib 115
New targeted molecular therapies for dedifferentiated thyroid cancer. 114
Analysis of chromosome damage in circulating lymphocytes of radiological workers affected by thyroid nodules 114
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 113
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 112
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 111
Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident 111
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up 111
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 110
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 110
Antibodies recognizing specific Mycobacterium avium subsp. paratuberculosis's MAP3738c protein in type 1 diabetes mellitus children are associated with serum Th1 (CXCL10) chemokine. 109
TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation 109
New targeted therapies for anaplastic thyroid cancer. 108
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 108
Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature 108
The Role of Total Thyroidectomy in the Initial Treatment of Well-differentiated Follicular-cell-derived Thyroid Carcinomas 107
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 106
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. 105
Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer 105
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 105
Thyroid cancer in HCV-related mixed cryoglobulinemia patients. 104
null 104
Hepatitis C virus infection - Evidence for an association with type 2 diabetes 104
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 104
The emerging extrahepatic manifestations oh hepatitis C virus infection in chronic hepatitis and mixed cryoglobulinemia. 103
null 103
CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation 103
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 103
Tyrosine Kinase Inhibitors; Therapies for Thyroid Cancer 103
null 103
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis 102
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. 102
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study 102
Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis. 100
null 100
Autoimmune thyroid disorders 100
Novel treatment options for anaplastic thyroid cancer 100
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 100
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 100
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 100
Dedifferentiated thyroid cancer: a therapeutic challenge 99
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis. 99
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 98
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. 98
Body composition and cardiac dimensions in elite rhythmic gymnasts 98
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 98
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition 98
Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes 97
Changes in autonomic regulation and ventricular repolarization induced by subclinical hyperthyroidism 97
Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. 97
Deregulated expression of VHL mRNA variants in papillary thyroid cancer 97
Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease 97
null 97
Selective use of vandetanib in the treatment of thyroid cancer 96
Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer 96
Prevalence of hypothyroidism and Graves disease in sarcoidosis 95
Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis. 95
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration. 95
Current and future immunotherapies for thyroid cancer 95
The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer 94
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. 93
Anti CD-38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves’ disease. 93
Totale 11.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.434 0 0 0 0 0 0 0 0 0 0 760 674
2019/20206.662 639 337 935 355 520 548 699 620 1.021 430 405 153
2020/20212.728 267 224 298 98 182 98 83 361 172 322 143 480
2021/20223.378 70 154 119 214 554 460 97 223 171 145 228 943
2022/20233.428 502 409 225 306 373 504 58 249 498 15 242 47
2023/20242.537 290 325 360 230 429 521 144 108 47 54 29 0
Totale 25.153